Online
|
|
nifty next few days touch 3500 level...
if market breake down next days or dip ril,sbi,rel infra...
rcomm next target 250 buy any dip...
watch in ndtv next target150 if market give support...
dear brother watch on rel power next target 150...
yes this is possible brother...
It could b possible. Thanks....
yes.. it would touch... but unexpectedly.. for a short time.. it would touch and fall back.. it happened in the past many times. within this range 208-228...
If it trades above 208 for 2-3 days then it can touch 228 very shortly....
Updates
Posted by :
LEO THE LIONWhen there is no requirement of this plant ,then they can sell this ............
Updates
Posted by : vkk43
Piramal Healthcare Ltd has informed BSE that as a part of consolidation of global manufacturing assets, the Company has decided to discontinue operations at its manufacturing facility in Huddersfield, UK. This is an Intermediate / API site catering to the Pharma Solutions (Custom Manufacturing) business and is one of the manufacturing sites of Piramal Healthcare (UK) Ltd., the Company`s wholly-owned subsidiary in the UK.
In 2005, Piramal Healthcare acquired Avecia Pharmaceuticals which was then renamed as NPIL Pharmaceuticals (UK) Ltd. (now known as Piramal Healthcare(UK) Ltd.). The Company had manufacturing facilities in Huddersfield, Grangemouth (Scotland) and Toronto (Canada). The remaining two sites at Grangemouth and Toronto will continue to operate and drive growth for the Pharma Solutions business.
The closure will result in a one time cash cost of approximately Rs 70 crores which will be incurred in the year ended March 31, 2009. As a result of this closure and increased acceptance of India as a custom manufacturing destination, profitability of the Pharma Solutions business is expected to increase significantly....
NSE Announcements on Piramal Health
Posted by : MMB MessengerPiramal Healthcare Limited has informed the Exchange that "As a part of consolidation of global manufacturing assets, Piramal Healthcare has decided to discontinue operations at its manufacturing facility in Huddersfield, UK. This is an Intermediate/API site catering to the Pharma Solutions (Custom Manufacturing) business and is one of the manufacturing sites of Piramal Healthcare (UK) Ltd., the Companys wholly-owned subsidiary in the UK. In 2005, Piramal Healthcare acquired Avecia Pharmaceuticals which was then renamed as NPIL Pharmaceuticals (UK) Ltd. (now known as Piramal Healthcare (UK) Ltd.). The Company had manufacturing facilities in Huddersfield. Grangemouth (Scotland) and Toronto (Canada). The remaining two sites at Grangemouth and Toronto will continue to operate and drive growth for the Pharma Solutions business. The closure will result in a one time cash cost of approximately Rs. 70 crores which will be incurred in the year ended March 31, 2009. As a result of this closure and increased acceptance of India as a custom manufacturing destination, profitability of the Pharma Solutions business is expected to increase significantly"....
BSE Announcements on Piramal Health
Posted by : MMB Messenger
Piramal Healthcare Ltd has informed BSE that as a part of consolidation of global manufacturing assets, the Company has decided to discontinue operations at its manufacturing facility in Huddersfield, UK. This is an Intermediate / API site catering to the Pharma Solutions (Custom Manufacturing) business and is one of the manufacturing sites of Piramal Healthcare (UK) Ltd., the Companys wholly-owned subsidiary in the UK.
In 2005, Piramal Healthcare acquired Avecia Pharmaceuticals which was then renamed as NPIL Pharmaceuticals (UK) Ltd. (now known as Piramal Healthcare(UK) Ltd.). The Company had manufacturing facilities in Huddersfield, Grangemouth (Scotland) and Toronto (Canada). The remaining two sites at Grangemouth and Toronto will continue to operate and drive growth for the Pharma Solutions business.
The closure will result in a one time cash cost of approximately Rs 70 crores which will be incurred in the year ended March 31, 2009. As a result of this closure and increased acceptance of India as a custom manufacturing destination, profitability of the Pharma Solutions business is expected to increase significantly....
NSE Announcements on Piramal Health
Posted by : MMB MessengerPiramal Healthcare Limited has informed the Exchange that Ms Nandini Piramal has been appointed as an Executive Director on the Board of the Company. Ms.Nandini Piramal is the daughter of Mr. Ajay Piramal and Dr. Swati Piramal and belongs to the Promoter Group. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
BSE Announcements on Piramal Health
Posted by : MMB MessengerPiramal Healthcare Ltd has informed BSE that Ms. Nandini Piramal has been appointed as an Executive Director on the Board of the Company....
